Labrucherie Gil M
SEC CIK 1394875 · EDGAR
BoughtSold
Most active insiders at RZLT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Evans Daron | CFO | $161.4K | — |
| 2 | Elam Nevan C | CEO, Dir | $50.9K | — |
| 3 | ROBERTS BRIAN KENNETH | Chief Medical Off | $47.6K | — |
| 4 | Karnawat Sunil Ratilal | Chief Commercial Off | $19.6K | — |
| 5 | Hogenhuis Wladimir | Dir | $9,548 | — |
| 6 | FAUCHET PHILIPPE | Dir | — | — |
| 7 | Harris Erik | Dir | — | — |
| 8 | Kim Young-Jin | Dir | — | — |
| 9 | KREHER NERISSA | Dir | — | — |
| 10 | Labrucherie Gil M | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-21 | 2025-11-19 | RZLT | Rezolute, Inc. | Labrucherie Gil M | Dir | A - Grant | $0.00 | +21.0K | 55.5K | +61% | $0 |
| D | 2025-06-13 | 2025-06-10 | RZLT | Rezolute, Inc. | Labrucherie Gil M | Dir | A - Grant | $0.00 | +9,000 | 34.5K | +35% | $0 |
| MI | 2025-02-27 | 2025-02-25+ | SEPN | Septerna, Inc. | Labrucherie Gil M | CFO | P - Purchase | $5.69 | +10.0K | 40.0K | +33% | +$56.9K |
| MI | 2025-02-21 | 2025-02-19+ | SEPN | Septerna, Inc. | Labrucherie Gil M | CFO | P - Purchase | $5.75 | +30.0K | 10.5K | New | +$172.4K |
| D | 2025-02-20 | 2025-02-16 | RZLT | Rezolute, Inc. | Labrucherie Gil M | Dir | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| 2022-05-17 | 2022-05-15 | NKTR | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO, CFO | A - Grant | $0.00 | +28.8K | 330.4K | +10% | $0 | |
| 2022-05-17 | 2022-05-16 | NKTR | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO, CFO | S - Sale | $3.95 | -17.4K | 312.9K | -5% | -$68.9K | |
| AI | 2022-05-09 | 2022-05-04 | RZLT | Rezolute, Inc. | Labrucherie Gil M | Dir | P - Purchase | $3.80 | +52.6K | 53.6K | +5,593% | +$200.0K |
| 2022-05-06 | 2022-05-04 | RZLT | Rezolute, Inc. | Labrucherie Gil M | Dir | P - Purchase | $3.80 | +52.6K | 52.6K | New | +$200.0K | |
| 2022-02-18 | 2022-02-16 | NKTR | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO, CFO | S - Sale | $10.95 | -7,579 | 301.6K | -2% | -$83.0K | |
| D | 2021-12-20 | 2021-12-16 | NKTR | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO, CFO | A - Grant | $0.00 | +53.0K | 309.2K | +21% | $0 |
| M | 2021-11-18 | 2021-11-16+ | NKTR | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO, CFO | S - Sale | $13.10 | -24.1K | 259.7K | -9% | -$316.4K |
| 2021-11-17 | 2021-11-15 | NKTR | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO, CFO | A - Grant | $0.00 | +40.1K | 280.8K | +17% | $0 | |
| M | 2021-08-18 | 2021-08-16+ | NKTR | NEKTAR THERAPEUTICS | Labrucherie Gil M | SVP, COO, CFO | S - Sale | $13.76 | -10.9K | 240.2K | -4% | -$149.5K |
Purchase Sale Sale after option exercise All abbreviations